Regulation & Compliance

A wound care gel recall by Blaine Labs reveals a history of contamination issues and prior FDA warnings, posing serious risks to vulnerable patients.

Lupin wins FDA approval for its generic dapagliflozin, a move set to slash costs for a blockbuster diabetes and heart drug and reshape patient care.

After three rejections, Outlook Therapeutics escalates its fight for US approval of a key wet AMD drug, already sold in Europe. Will the FDA bend?

The leading health system is deploying Midstream Health's AI agents to tackle operational costs and secure long-term financial sustainability.

As AI chatbots transform how renters find apartments, one VC firm is betting on the startups that will help properties stay visible in a post-search world.

A new minimally invasive stent for complex aortic arch disease receives FDA approval, offering hope to high-risk patients previously deemed untreatable.

A new generative AI agent is slashing weeks of traffic data analysis into minutes, freeing up engineers to finally solve urban mobility challenges.

The Texas-based firm's innovative fraud and compliance tech earns a top Inc. ranking, highlighting its crucial role in a high-stakes industry.

Harvard Business Review's 2025 prize signals a new era for leadership, rewarding a practical framework that moves beyond AI hype to strategic implementation.

Thousands of Colorado families with employer-sponsored Anthem plans gain in-network access to top pediatric care, but individual plan members are left out.

Manufacturers warn new laws on AI, climate, and taxes could cripple the state's $382B industry, while proponents push for worker and climate protection.

Smarter Technologies launches SmarterUtilization, an AI platform tackling the costly, manual process of utilization management. Can it fix healthcare's bottom line?

The Utah Bankers Association endorses Stablecore, signaling a major shift for regional banks into the world of stablecoins and tokenized assets.

As lung cancer becomes a growing crisis for women, the LCRF gala honors two leaders driving change and rallying support for life-saving research.

With a new $11M investment, Cyberhill Partners leverages its defense-grade expertise to solve the 95% failure rate plaguing enterprise AI projects.

Meet three social enterprises in Pakistan, South Africa, & India whose proven models for change just earned them the prestigious $2M Skoll Award.

A US-Uruguay collaboration is using novel REJOIN-seq tech to find hidden RNA triggers of lupus, paving the way for safer, non-immunosuppressive drugs.

Ontario and Quebec expand public coverage for a potent cholesterol drug, offering a critical lifeline to thousands at risk of a second cardiovascular event.

The wealth tech leader unveils its InsightX platform and AI Innovation Lab, designed to make advanced analytics accessible to all financial professionals.

Major insurers report an 11% drop in prior authorizations, a first step in a larger reform effort. But providers and advocates question if it's enough.